Clinical Trial Update: Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

This document reports an update on a Phase I trial evaluating continuous hyperthermic peritoneal perfusion with cisplatin, followed by early postoperative intra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Peritoneal Neoplasm | Phase 1 | Status: COMPLETED